Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tegafur. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102285972A details a green microwave-assisted route for Tegafur, eliminating toxic chloroform and reducing energy consumption for cost-effective manufacturing.
Novel mild preparation of antineoplastic drug tegafur using 2-benzoyloxy tetrahydrofuran. High yield, >99.7% purity, scalable industrial process.
Patent CN104513230A reveals high-purity Tegafur synthesis using supported catalysts. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Discover a novel metal-free synthesis of Tegafur using organic ammonium salts. This patent offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103159746B reveals a high-yield Tegafur synthesis method. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Novel dimethylchlorosilane activation method for Tegafur ensures 99.9% purity and mild conditions. Ideal for reliable API intermediate suppliers seeking cost reduction.
Patent CN107235967B reveals a green, mild synthesis of Tegafur using 5-fluorouracil and THF. Discover cost-effective manufacturing strategies for high-purity antineoplastic intermediates.